Patent details

EP1490030 Title: NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS

Basic Information

Publication number:
EP1490030
PCT Application Number:
PCT/US/2003/008546
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037237815
PCT Publication Number:
WO/2003/080027
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
French Title of Invention:
COMPOSITIONS NANOPARTICULAIRES D'INHIBITEURS D'ANGIOGENESE
German Title of Invention:
NANOPARTIKELZUSAMMENSETZUNGEN VON ANGIOGENESEINHIBITOREN
SPC Number:

Dates

Filing date:
20/03/2003
Grant date:
25/10/2006
EP Publication Date:
25/10/2006
PCT Publication Date:
02/10/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/12/2004
EP B1 Publication Date:
25/10/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/03/2007
Expiration date:
20/03/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/03/2003
 
 

Name:
Elan Pharma International Limited
Address:
WIL House, Shannon Business Park, Shannon, County Clare, Ireland (IE)

Inventor

1

Name:
JAIN Rajeev
Address:
United States (US)

2

Name:
RYDE Tuula
Address:
United States (US)

3

Name:
WALTERS Amy
Address:
United States (US)

4

Name:
PRUITT John
Address:
United States (US)

5

Name:
BOSCH H., William
Address:
United States (US)

6

Name:
CARY Greta, G.
Address:
United States (US)

7

Name:
MERISKO-LIVERSIDGE Elaine
Address:
United States (US)

Priority

1

Priority Number:
365540 P
Priority Date:
20/03/2002
Priority Country:
United States (US)

2

Priority Number:
366542 P
Priority Date:
25/03/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/14;
Filing date Document type Number of pages